Haojing Rong Email

VP Preclinical Development . Kymera Therapeutics

Current Roles

Employees:
203
Revenue:
$25.6M
About
Kymera Therapeutics is pioneering a transformative new approach to treating previously untreatable diseases. We are advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade rather than inhibit dysregulated, disease-causing proteins. Powered by a proprietary predictive modeling capability and a game-changing integrated degradation platform with a novel small molecule modality, our company is committed to accelerating drug discovery with an unmatched ability to target and degrade the most intractable of proteins, and advance new treatment options for patients. Learn more at kymeratx.com.
Kymera Therapeutics Address
200 Arsenal Yards Blvd.
Cambridge, MA
United States

Past Companies

Atlas Venture NewCoSVP, Translational Science
Kymera TherapeuticsVice President Of Preclinical Development
Kymera TherapeuticsExecutive Director of Preclinical Development

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.